XML 69 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity (Tables)
9 Months Ended
Sep. 30, 2015
Equity  
Summary of AbbVie stock option activity for both AbbVie and Abbott employees

(options in thousands, aggregate intrinsic value in millions)

 

Options

 

Weighted-
average
exercise
price

 

Weighted-
average
remaining life
(in years)

 

Aggregate
intrinsic value

 

Outstanding at December 31, 2014

 

28,280

 

$
28.53

 

3.3

 

$
1,044

 

Granted

 

1,207

 

58.83

 

 

 

 

 

Exercised

 

(5,002

)

26.71

 

 

 

 

 

Lapsed

 

(43

)

27.39

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2015

 

24,442

 

30.40

 

3.2

 

$
592

 

 

 

 

 

 

 

 

 

 

 

Exercisable at September 30, 2015

 

21,964

 

$
27.99

 

2.6

 

$
580

 

 

 

 

 

 

 

 

 

 

 

 

Summary of AbbVie RSA and RSU activity (including performance-based awards) for both AbbVie and Abbott employees

(share units in thousands)

 

Share units

 

Weighted-average
grant date fair value

 

Outstanding at December 31, 2014

 

12,815

 

$
40.98

 

Granted

 

5,863

 

61.03

 

Vested

 

(5,608

)

37.36

 

Lapsed

 

(456

)

48.77

 

 

 

 

 

 

 

Outstanding at September 30, 2015

 

12,614

 

$
51.62

 

 

 

 

 

 

 

 

Summary of changes in balances of each component of accumulated other comprehensive loss

(in millions) (brackets denote losses)

 

Foreign
currency
translation
adjustments

 

Pension

and post-
employment
benefits

 

Unrealized
gains on
marketable
equity

securities

 

Hedging
activities

 

Total

 

Balance as of December 31, 2014

 

$
(603

)

$
(1,608

)

$
3

 

$
177

 

$
(2,031

)

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive (loss) income before reclassifications

 

(464

)

23

 

 

78

 

(363

)

Amounts reclassified from accumulated other comprehensive loss

 

 

68

 

(4

)

(169

)

(105

)

 

 

 

 

 

 

 

 

 

 

 

 

Net current-period other comprehensive (loss) income

 

(464

)

91

 

(4

)

(91

)

(468

)

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of September 30, 2015

 

$
(1,067

)

$
(1,517

)

$
(1

)

$
86

 

$
(2,499

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions) (brackets denote losses)

 

Foreign
currency
translation
adjustments

 

Pension

and post-
employment
benefits

 

Unrealized
gains on
marketable
equity

securities

 

Hedging
activities

 

Total

 

Balance as of December 31, 2013

 

$
470

 

$
(827

)

$
2

 

$
(87

)

$
(442

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive (loss) income before reclassifications

 

(714

)

 

(1

142

 

(573

)

Amounts reclassified from accumulated other comprehensive loss

 

 

43

 

 

59

 

102

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net current-period other comprehensive (loss) income

 

(714

)

43

 

(1

201

 

(471

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of September 30, 2014

 

$
(244

$
(784

)

$
1

 

$
114

 

$
(913

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of the significant amounts reclassified out of each component of accumulated other comprehensive loss

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

(in millions) (brackets denote gains)

 

2015

 

2014

 

2015

 

2014

 

Pension and post-employment benefits

 

 

 

 

 

 

 

 

 

Amortization of actuarial losses and other (a)

 

$
31

 

$
27

 

$
96

 

$
59

 

Less tax benefit

 

(10

)

(7

)

(28

)

(16

)

 

 

 

 

 

 

 

 

 

 

Total reclassification, net of tax

 

$
21

 

$
20

 

$
68

 

$
43

 

 

 

 

 

 

 

 

 

 

 

Hedging activities

 

 

 

 

 

 

 

 

 

(Gains) losses on designated cash flow hedges (b)

 

$
(89

)

$
23

 

$
(171

)

$
59

 

Less tax expense

 

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

Total reclassification, net of tax

 

$
(89

)

$
23

 

$
(169

)

$
59

 

 

 

 

 

 

 

 

 

 

 

 

(a) Amounts are included in the computation of net periodic benefit cost (see Note 9).

(b) Amounts are included in cost of products sold (see Note 8).